Gene · 23409
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide Study of Diabetes Mellitus (Type 2)-Associated Genes in Homo sapiens (Human). | J Gene Med | 2025 | 40462586 | PubTator, text mining | PubMed |
| SIRT4 Controls Acetyl-CoA Synthesis to Promote Stemness and Invasiveness of Hepatocellular Carcinoma through Deacetylating MCCC2. | Int J Biol Sci | 2025 | 40384857 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
| Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications. | Front Immunol | 2025 | 40370433 | PubTator, text mining | PubMed |
| SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling. | Adv Sci (Weinh) | 2025 | 40298941 | PubTator, text mining | PubMed |
| l-Carnitine and Acetyl-l-Carnitine Induce Metabolism Alteration and Mitophagy-Related Cell Death in Colorectal Cancer Cells. | Nutrients | 2025 | 40290068 | PubTator, text mining | PubMed |
| Krüppel-like factors in mitochondrial quality control. | Front Physiol | 2025 | 40265156 | PubTator, text mining | PubMed |
| Lysine-specific demethylase 1 (LSD1) suppresses cellular senescence by riboflavin uptake-dependent demethylation activity. | Sci Rep | 2025 | 39988719 | PubTator, text mining | PubMed |
| Diurnal variation in skeletal muscle mitochondrial function dictates time-of-day-dependent exercise capacity. | FASEB J | 2025 | 39902884 | PubTator, text mining | PubMed |
| Gut Microbiome and Metabolome Changes in Chronic Low Back Pain Patients With Vertebral Bone Marrow Lesions. | JOR Spine | 2025 | 39877797 | PubTator, text mining | PubMed |
| The curious case of mitochondrial sirtuin in rewiring breast cancer metabolism: Mr Hyde or Dr Jekyll? | Biochim Biophys Acta Mol Basis Dis | 2025 | 39864670 | PubTator, text mining | PubMed |
| Inhibition of SIRT4 promotes bladder cancer progression and immune escape via attenuating CD8+ T cells function. | Int Immunopharmacol | 2025 | 39756164 | PubTator, text mining | PubMed |
| Targeting sirtuins in neurological disorders: A comprehensive review. | Int J Biol Macromol | 2025 | 39736297 | PubTator, text mining | PubMed |
| [Retracted] SIRT4 overexpression protects against diabetic nephropathy by inhibiting podocyte apoptosis. | Exp Ther Med | 2025 | 39720670 | PubTator, text mining | PubMed |
| [Corrigendum] Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1‑5 and increased expression of SIRT 6 and 7. | Int J Mol Med | 2025 | 39704217 | PubTator, text mining | PubMed |
| Sirt4 Overexpression Modulates the JAK2/STAT3 and PI3K/AKT/mTOR Axes to Alleviate Sepsis-Induced Acute Lung Injury. | Cell Biochem Biophys | 2025 | 39400781 | PubTator, text mining | PubMed |
| SIRT4 is associated with microvascular infiltration, immune cell infiltration, and epithelial mesenchymal transition in hepatocellular carcinoma. | Histol Histopathol | 2025 | 39082202 | PubTator, text mining | PubMed |
| Molecular Sentinels: Unveiling the Role of Sirtuins in Prostate Cancer Progression. | Int J Mol Sci | 2024 | 39796040 | PubTator, text mining | PubMed |
| Editorial: Redox signaling and homeostasis in the control of metabolism: a systemic interplay between central and peripheral effectors. | Front Endocrinol (Lausanne) | 2024 | 39691314 | PubTator, text mining | PubMed |
| Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications. | Cancers (Basel) | 2024 | 39682281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23409/papers?page=4